Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

WOONSOCKET, R.I. - CVS Health (NYSE: CVS )周一宣布，其董事会已批准对公司普通股每股派发0.665美元的季度股息。 根据这家医疗保健公司的新闻声明，该股息将于2025年8月1日支付给截至2025年7月22日的在册股东。

Nichols & Pratt Advisers sold 7,627 CVS Health shares in Q1, lowering its stake by 6.9%, SEC filings show. The firm now holds ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

One way to get an idea of the market sentiment on a stock is to check its rate of institutional ownership. In the case of CVS ...

Mirae Asset Global Investments Co. Ltd. juiced up its stake in CVS Health Corporation by a healthy 12.6%, showcasing a robust ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...